Home › Funds › DIADEMA PARTNERS LP › GMAB
DIADEMA PARTNERS LP position in GMAB
GENMAB A/S · Health Care
DIADEMA PARTNERS LP reported holding 518,100 shares of GMAB (GENMAB A/S) in its Q3 2026 13F filing — a position valued at US$18.5M, representing 4.96% of its reported portfolio and ranking #4 among its reported holdings. DIADEMA PARTNERS LP first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How DIADEMA PARTNERS LP's GMAB position evolved
DIADEMA PARTNERS LP first disclosed a stake in GMAB in Q3 2026 at 518,100 shares (US$18.5M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 518.10K | $18.48M | New |
About GMAB and 13F data
GMAB (GENMAB A/S) is a Health Care company. 36 other funds we track also report a position in GMAB — the largest reported positions include Paradigm Biocapital Advisors LP (US$504.3M), Orbis Allan Gray Ltd (US$377.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$188.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GMAB
- Paradigm Biocapital Advisors LP 14.14M sh · $504.32M · Q3 2026
- Orbis Allan Gray Ltd 10.57M sh · $376.99M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 6.87M sh · $188.58M · Q2 2026
- Sofinnova Investments, Inc. 4.35M sh · $155.17M · Q3 2026
- HARDING LOEVNER LP 2.90M sh · $134.23M · Q3 2026
- Deep Track Capital, LP 2.76M sh · $98.46M · Q3 2026
More on DIADEMA PARTNERS LP
FAQ
How long has DIADEMA PARTNERS LP held GMAB?
DIADEMA PARTNERS LP has disclosed GMAB holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is DIADEMA PARTNERS LP's current position in GMAB?
As of Q3 2026, DIADEMA PARTNERS LP holds 518.10K shares of GMAB (GENMAB A/S), valued at $18.48M, representing 4.96% of its reported portfolio and ranking #4.
Has DIADEMA PARTNERS LP been buying or selling GMAB?
In the latest 13F filing (Q3 2026), DIADEMA PARTNERS LP newly opened its position in GMAB.
Which other funds hold GMAB?
Other major institutional holders of GMAB include Paradigm Biocapital Advisors LP, Orbis Allan Gray Ltd, DEERFIELD MANAGEMENT COMPANY, L.P., among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.